leadf
logo-loader
viewBeroni Group

Beroni Group looking to up-list to the Nasdaq

Beroni Group Inc (BNIGF:OTCQX) (ASX:BTG) CEO Jacky Zhang sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Australian-based company currently has four core businesses: research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

Quick facts: Beroni Group

Price: 2.15 USD

OTCQX:BNIGF
Market: OTCQX
Market Cap: $162.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Chimeric Therapeutics new very experienced COO has bold vision to move CAR T...

Chimeric Therapeutics (ASX: CHM) newly appointed COO Jennifer Chow joined Steve Darling from Proactive to talk about her vision for the company. Chow talks about her background working in cell therapy and how Chimeric hopes to be a big player in it. Chow also told Proactive about their lead...

1 hour, 8 minutes ago

2 min read